ID27820A - APLIKASI-APLIKASI PENGOBATAN POLIPEPTIDA MATURE FLINT (mFLINT) ATAU OPG3, BAGIAN KELOMPOK SUPER RESEPTOR TNF - Google Patents
APLIKASI-APLIKASI PENGOBATAN POLIPEPTIDA MATURE FLINT (mFLINT) ATAU OPG3, BAGIAN KELOMPOK SUPER RESEPTOR TNFInfo
- Publication number
- ID27820A ID27820A IDW20001948A ID20001948A ID27820A ID 27820 A ID27820 A ID 27820A ID W20001948 A IDW20001948 A ID W20001948A ID 20001948 A ID20001948 A ID 20001948A ID 27820 A ID27820 A ID 27820A
- Authority
- ID
- Indonesia
- Prior art keywords
- mflint
- opg3
- polipeptide
- receptor
- applications
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7985698P | 1998-03-30 | 1998-03-30 | |
US8607498P | 1998-05-20 | 1998-05-20 | |
US9964398P | 1998-09-09 | 1998-09-09 | |
US11257798P | 1998-12-17 | 1998-12-17 | |
US11270398P | 1998-12-18 | 1998-12-18 | |
US11293398P | 1998-12-18 | 1998-12-18 | |
US11340798P | 1998-12-22 | 1998-12-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
ID27820A true ID27820A (id) | 2001-04-26 |
Family
ID=27568394
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW20001948A ID27820A (id) | 1998-03-30 | 1999-03-30 | APLIKASI-APLIKASI PENGOBATAN POLIPEPTIDA MATURE FLINT (mFLINT) ATAU OPG3, BAGIAN KELOMPOK SUPER RESEPTOR TNF |
Country Status (16)
Country | Link |
---|---|
US (1) | US20040167074A1 (pt) |
JP (1) | JP2002512006A (pt) |
KR (1) | KR20010042364A (pt) |
CN (1) | CN1303429A (pt) |
AU (1) | AU3369199A (pt) |
BR (1) | BR9909328A (pt) |
CA (1) | CA2324517A1 (pt) |
CZ (1) | CZ20003433A3 (pt) |
EA (1) | EA200001004A1 (pt) |
HU (1) | HUP0102067A2 (pt) |
ID (1) | ID27820A (pt) |
IL (1) | IL138626A0 (pt) |
NO (1) | NO20004873L (pt) |
PL (1) | PL343847A1 (pt) |
TR (1) | TR200002824T2 (pt) |
WO (1) | WO1999050413A2 (pt) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69837996T2 (de) | 1997-01-14 | 2008-02-28 | Human Genome Sciences, Inc. | Tumornekrosefaktor-rezeptoren 6 alpha& 6 beta |
US7285267B2 (en) | 1997-01-14 | 2007-10-23 | Human Genome Sciences, Inc. | Tumor necrosis factor receptors 6α & 6β |
CA2303225C (en) | 1997-09-18 | 2015-03-31 | Genentech, Inc. | Dna30942 polypeptide, a tnfr homolog |
WO2000037094A2 (en) * | 1998-12-22 | 2000-06-29 | Eli Lilly And Company | Therapeutic applications of flint polypeptides |
DE60036199T2 (de) * | 1999-03-30 | 2008-05-21 | Eli Lilly And Co., Indianapolis | Proteaseresistente flint-analoge |
US6627199B1 (en) | 1999-07-09 | 2003-09-30 | Amgen Inc | Isolation, identification and characterization of tmst2, a novel member of the TNF-receptor supergene family |
AU783682B2 (en) | 1999-08-04 | 2005-11-24 | Amgen, Inc. | Fhm, a novel member of the TNF ligand supergene family |
AU6517800A (en) | 1999-08-04 | 2001-03-05 | Amgen, Inc. | Ntr3, a member of the tnf-receptor supergene family |
WO2001018041A2 (en) * | 1999-09-10 | 2001-03-15 | Eli Lilly And Company | Flint proteins and formulations thereof |
AU1189101A (en) * | 1999-10-20 | 2001-04-30 | Eli Lilly And Company | Therapeutic applications of flint polypeptides |
AU1915201A (en) * | 1999-12-07 | 2001-06-18 | Eli Lilly And Company | Improving stability of flint through o-linked glycosylation |
EP1322667A4 (en) * | 2000-08-25 | 2004-08-18 | Human Genome Sciences Inc | TUMOR NECROSIS FACTOR RECEPTORS 6-ALPHA AND 6-BETA |
EP1364653A4 (en) * | 2001-02-23 | 2005-01-26 | Takeda Pharmaceutical | CASOASE-3 INHIBITORS |
AU2004224123A1 (en) | 2003-03-26 | 2004-10-07 | Apogenix Gmbh | Treatment of viral infections |
EP1841442A4 (en) * | 2005-01-07 | 2009-12-09 | Northern Sydney And Central Co | TREATMENT OF AUTOIMMUNE DISEASES AND INFLAMMATORY DISEASES |
JP5558828B2 (ja) | 2006-12-28 | 2014-07-23 | ドイチェス クレープスフォルシュングスツェントルム | インビボでの神経膠芽腫細胞の浸潤を阻害するcd95活性の中和 |
EP2318441A2 (en) * | 2008-07-14 | 2011-05-11 | Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts | Use of cd95 inhibitors for the treatment of inflammatory disorders |
CN102671186B (zh) * | 2011-09-19 | 2014-08-06 | 上海市肿瘤研究所 | 促造血的药物组合物及其应用 |
AU2013291981B2 (en) | 2012-07-18 | 2017-05-04 | Apogenix Ag | Inhibitors of the CD95 signaling pathway for treatment of MDS |
EP3076179A1 (en) | 2015-03-30 | 2016-10-05 | Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts | Diagnosis and treatment of low grade gliomas |
US11007253B2 (en) | 2015-12-18 | 2021-05-18 | Talengen International Limited | Method for preventing or treating radiation and chemical damage |
TWI623321B (zh) | 2015-12-18 | 2018-05-11 | Talengen Institute Of Life Sciences Co Ltd | Method for preventing and treating cervical erosion |
WO2020205662A1 (en) | 2019-03-29 | 2020-10-08 | Myst Therapeutics, Inc. | Ex vivo methods for producing a t cell therapeutic and related compositions and methods |
JP2023504042A (ja) | 2019-11-27 | 2023-02-01 | ミスト セラピューティクス リミテッド ライアビリティ カンパニー | 調節物質を使用した腫瘍反応性t細胞組成物の生成方法 |
WO2021174208A1 (en) | 2020-02-27 | 2021-09-02 | Myst Therapeutics, Llc | Methods for ex vivo enrichment and expansion of tumor reactive t cells and related compositions thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69837996T2 (de) * | 1997-01-14 | 2008-02-28 | Human Genome Sciences, Inc. | Tumornekrosefaktor-rezeptoren 6 alpha& 6 beta |
US5885800A (en) * | 1997-02-04 | 1999-03-23 | Smithkline Beecham Corporation | DNA encoding tumor necrosis related receptor, TR4 |
AU9013998A (en) * | 1997-07-21 | 1999-02-10 | Zymogenetics Inc. | Tumor necrosis factor receptor ztnfr-5 |
WO1999007738A2 (en) * | 1997-08-06 | 1999-02-18 | Regeneron Pharmaceuticals, Inc. | Human orphan receptor ntr-1 |
CA2303225C (en) * | 1997-09-18 | 2015-03-31 | Genentech, Inc. | Dna30942 polypeptide, a tnfr homolog |
AU1535699A (en) * | 1997-11-24 | 1999-06-15 | Apotech S.A. | Novel receptors opg-2 |
-
1999
- 1999-03-30 CN CN99806639A patent/CN1303429A/zh active Pending
- 1999-03-30 BR BR9909328-6A patent/BR9909328A/pt not_active Application Discontinuation
- 1999-03-30 CA CA002324517A patent/CA2324517A1/en not_active Abandoned
- 1999-03-30 IL IL13862699A patent/IL138626A0/xx unknown
- 1999-03-30 TR TR2000/02824T patent/TR200002824T2/xx unknown
- 1999-03-30 EA EA200001004A patent/EA200001004A1/ru unknown
- 1999-03-30 ID IDW20001948A patent/ID27820A/id unknown
- 1999-03-30 KR KR1020007010929A patent/KR20010042364A/ko not_active Application Discontinuation
- 1999-03-30 PL PL99343847A patent/PL343847A1/xx unknown
- 1999-03-30 CZ CZ20003433A patent/CZ20003433A3/cs unknown
- 1999-03-30 AU AU33691/99A patent/AU3369199A/en not_active Abandoned
- 1999-03-30 JP JP2000541301A patent/JP2002512006A/ja not_active Withdrawn
- 1999-03-30 HU HU0102067A patent/HUP0102067A2/hu unknown
- 1999-03-30 WO PCT/US1999/006797 patent/WO1999050413A2/en not_active Application Discontinuation
-
2000
- 2000-09-28 NO NO20004873A patent/NO20004873L/no unknown
-
2004
- 2004-03-04 US US10/793,269 patent/US20040167074A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20040167074A1 (en) | 2004-08-26 |
IL138626A0 (en) | 2001-10-31 |
WO1999050413A2 (en) | 1999-10-07 |
NO20004873L (no) | 2000-11-24 |
TR200002824T2 (tr) | 2000-12-21 |
AU3369199A (en) | 1999-10-18 |
HUP0102067A2 (hu) | 2001-10-28 |
CZ20003433A3 (cs) | 2001-10-17 |
BR9909328A (pt) | 2000-12-12 |
EA200001004A1 (ru) | 2001-06-25 |
KR20010042364A (ko) | 2001-05-25 |
NO20004873D0 (no) | 2000-09-28 |
CA2324517A1 (en) | 1999-10-07 |
CN1303429A (zh) | 2001-07-11 |
WO1999050413A3 (en) | 1999-12-02 |
PL343847A1 (en) | 2001-09-10 |
JP2002512006A (ja) | 2002-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID27820A (id) | APLIKASI-APLIKASI PENGOBATAN POLIPEPTIDA MATURE FLINT (mFLINT) ATAU OPG3, BAGIAN KELOMPOK SUPER RESEPTOR TNF | |
BRPI0010891B1 (pt) | geração de microespuma terapêutica. | |
DK1047428T3 (da) | Anvendelse af morpholinol til behandlingen af seksualforstyrrelser | |
DE69902758D1 (de) | 2-(purin-9-yl)-tetrahydrofuran-3,4-diol-derivative | |
HK1040397A1 (en) | substituted benzopyran analogs for the treatment of inflammation. | |
DE59701304D1 (de) | Wirbelsäulenorthese | |
ID27841A (id) | Turunan-turunan biaril terapeutik | |
IT238006Y1 (it) | Dispositivo massaggiatore,ad elevata semplicita' strutturale,utilizzabile direttamente o inseribile all'interno dello schienale | |
DE69930330D1 (de) | Durchlaufwärmebehandlungsofen | |
BR9907304B1 (pt) | refratÁrio de alumina-magnÉsia-grafita. | |
IT1302243B1 (it) | Sintesi dell'1,1,1,3,3-pentafluoropropano. | |
ID27214A (id) | Triazolopiridina untuk pengobatan gangguan trombosis | |
ID26909A (id) | Turunan-turunan 1,3,4-oksadiazolon | |
IT1303677B1 (it) | Dispositivo per il trattamento termico di pezzi. | |
DE60025958D1 (de) | 14,15-beta-methylen substituierte androgene | |
NO20000456D0 (no) | Fremgangsmåte for fremstilling av 1,2-dikloretan | |
EP1117675A4 (en) | THE KADHERING SIMILAR PROTEIN AND METHOD FOR ITS MANUFACTURE | |
ATE234839T1 (de) | 4,5-azolo-oxindole | |
ID26368A (id) | Turunan-turunan 2 deoksi higromisin | |
IS5324A (is) | (S) 2-Metýlamínó-2-fenýl-n-bútýl 3,4,5-trímetoxý-bensóat, notkun þess til meðferðar á langvinnum sársauka | |
FR2721203B1 (fr) | Orthèse du membre inférieur. | |
NO20005743D0 (no) | Fremgangsmåte til fremstilling av 4,5-epoksymorfinan-6- oksyglukoronider | |
ITMI992457A0 (it) | Procedimento per la preparazione di (s)-n-terbutil-1,2,3,4-tetraidrois ochinolin-3-carbossiammide | |
NO20005856D0 (no) | Anvendelse av 1,1-diokso-perhydro-1,2,4-tiadiaziner | |
DK0994849T3 (da) | Fremgangsmåde til fremstilling af 2,4,5-triflour-benzonitril |